Search all trials

Find therapies in clinical trials near you – page 45

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Splenic marginal zone lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Rituximab and Zanubrutinib with Rituximab Alone for Untreated Patients with Splenic Marginal Zone Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Rituximab

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study on Advanced Liver Cancer: Evaluating Livmoniplimab and Budigalimab in Patients Without Prior Systemic Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drug

Study of Nivolumab, Relatlimab and Bevacizumab combination for patients with untreated advanced or metastatic liver cancer (hepatocellular carcinoma)

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Follicular lymphoma

Not recruiting

Registered drugNo placebo

Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Metastatic malignant melanoma

Not recruiting

Registered drugNo placebo

Study of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Io102 Hydrochloride

Contact Research Centre

Non-obstructive cardiomyopathy

Not recruiting

Investigational

Study on Mavacamten for Adults with Non-obstructive Hypertrophic Cardiomyopathy

Investigational

France

Participants:18–64 years · 65+ years
Substances:Mavacamten

Contact Research Centre

Diabetic nephropathy

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Finerenone and Empagliflozin in Adults with Chronic Kidney Disease and Type 2 Diabetes

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Empagliflozin

Contact Research Centre

Hereditary angioedema

Not recruiting

Investigational

Study on NTLA-2002 for Adults with Hereditary Angioedema Using Ziclumeran and Lonvoguran

Investigational

France

Participants:18–64 years · 65+ years
Substances:Lonvoguran

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Selpercatinib with a Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer+2

Not recruiting

Registered drug

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Registered drug

France

Participants:18–64 years · 65+ years

Contact Research Centre

Focal segmental glomerulosclerosis

Not recruiting

Investigational

Study of BI 764198 for Patients with Focal Segmental Glomerulosclerosis

Investigational

France

Participants:18–64 years · 65+ years
Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone

Contact Research Centre

Obstructive sleep apnoea syndrome

Not recruiting

Investigational

Study of Nacystelyn for Patients with Obstructive Sleep Apnea

Investigational

France

Participants:18–64 years · 65+ years
Substances:Nacystelyn

Contact Research Centre

Find therapies in clinical trials near you – page 45

654 trials match your criteria

Splenic marginal zone lymphoma

Study Comparing Rituximab and Zanubrutinib with Rituximab Alone for Untreated Patients with Splenic Marginal Zone Lymphoma

Hepatocellular carcinoma

Study on Advanced Liver Cancer: Evaluating Livmoniplimab and Budigalimab in Patients Without Prior Systemic Treatment

Hepatocellular carcinoma

Study of Nivolumab, Relatlimab and Bevacizumab combination for patients with untreated advanced or metastatic liver cancer (hepatocellular carcinoma)

Follicular lymphoma

Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

Metastatic malignant melanoma

Study of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma

Non-obstructive cardiomyopathy

Study on Mavacamten for Adults with Non-obstructive Hypertrophic Cardiomyopathy

Diabetic nephropathy

Study on the Effectiveness and Safety of Finerenone and Empagliflozin in Adults with Chronic Kidney Disease and Type 2 Diabetes

Hereditary angioedema

Study on NTLA-2002 for Adults with Hereditary Angioedema Using Ziclumeran and Lonvoguran

Non-small cell lung cancer

Study Comparing Selpercatinib with a Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

Non-small cell lung cancer+2

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Focal segmental glomerulosclerosis

Study of BI 764198 for Patients with Focal Segmental Glomerulosclerosis

Obstructive sleep apnoea syndrome

Study of Nacystelyn for Patients with Obstructive Sleep Apnea

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.